Chemistry:Uroporphyrinogen I

From HandWiki
Uroporphyrinogen I
Uroporphyrinogen I.svg
Names
IUPAC name
3,3′,3′′,3′′′-[3,8,13,18-Tetrakis(carboxymethyl)-10,15,20,22,23,24-hexahydro-5H,21H-porphyrin-2,7,12,17-tetrayl]tetrapropanoic acid
Systematic IUPAC name
3,3′,3′′,3′′′-[14,33,53,73-Tetrakis(carboxymethyl)-11H,31H,51H,71H-1,3,5,7(2,5)-tetrapyrrolacyclooctaphane-13,34,54,74-tetrayl]tetrapropanoic acid
Identifiers
3D model (JSmol)
ChemSpider
Properties
C40H44N4O16
Molar mass 836.804 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is ☑Y☒N ?)
Infobox references
Tracking categories (test):

Uroporphyrinogen I is an isomer of uroporphyrinogen III, a metabolic intermediate in the biosynthesis of heme. A type of porphyria is caused by production of uroporphyrinogen I instead of III.

Biosynthesis and metabolism

In living organisms, uroporphyrinogen I occurs as a side branch of the main porphyrin synthesis pathway. In the normal pathway, the linear tetrapyrrole precursor preuroporphyrinogen (a substituted hydroxymethylbilane) is converted by the enzyme uroporphyrinogen-III cosynthase into the cyclic uroporphyrinogen III; which is then converted to coproporphyrinogen III on the way to porphyrins like heme. Uroporphyrinogen I is instead produced spontaneously from preuroporphyrinogen when the enzyme is not present.[1][2]

Uroporphyrinogen I synthesis from preuroporphyrinogen

The difference between the I and III forms is the arrangement of the four carboxyethyl groups (propionic acid, "P") and the four carboxymethyl groups (acetic acid, "A"). The non-enzymatic conversion to uroporphyrinogen I results in the sequence AP-AP-AP-AP, whereas the enzymatic conversion into uroporphyrinogen III leads to reversal of one AP-group and hence an AP-AP-AP-PA arrangement.

If synthesized, uroporphyrinogen I is then converted into coproporphyrinogen I by the same enzyme (uroporphyrinogen decarboxylase) that acts on the III form; but that product, which is cytotoxic, then accumulates causing the pathology congenital erythropoietic porphyria.[2][3]

References

  1. Paul R. Ortiz de Montellano (2008). Wiley Encyclopedia of Chemical Biology. John Wiley & Sons. pp. 1–10. doi:10.1002/9780470048672.wecb221. ISBN 978-0470048672. 
  2. 2.0 2.1 Sassa, S.; Kappas, A. (2000). "Molecular aspects of the inherited porphyrias". Journal of Internal Medicine 247 (2): 169–178. doi:10.1046/j.1365-2796.2000.00618.x. PMID 10692079. 
  3. Di Pierro, Elena; Brancaleoni, Valentina; Granata, Francesca (2016). "Advances in understanding the pathogenesis of congenital erythropoietic porphyria". British Journal of Haematology 173 (3): 365–379. doi:10.1111/bjh.13978. PMID 26969896.